Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05755711 · ClinicalTrials.gov registry record
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
A clinical trial of Coronary Artery Disease, sponsored by Shockwave Medical.
- Active
- Registry status
- 399
- Enrollment target
- 20
- Study locations
NCT05755711: Active study of Coronary Artery Disease, sponsored by Shockwave Medical.
NCT05755711 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Shockwave Medical. The registered enrollment target is 399 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (69% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05755711, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Shockwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 399 participants
- Enrollment target
- 20
- Study locations
Study Summary
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Primary Outcome
Target lesion failure (TLF) at 30 days defined as a composite of cardiac death, myocardial infarction (per SCAI definition for peri-procedural MI; per 4th Universal Definition for spontaneous MI beyond discharge) attributable to target vessel (TV-MI), or ischemia-driven target lesion revascularization (ID-TLR).
Conditions Studied
Interventions
- DEVICE Shockwave Medical Coronary IVL System
Study Locations (20)
California
- Loma Linda University Health - Loma Linda
- Good Samaritan Hospital - Los Angeles
- Kaiser Permanente - San Francisco Medical Center - San Francisco
- Stanford University - Stanford
Georgia
- Emory Hospital - Atlanta
- Piedmont Heart Institute - Atlanta
- Northside Hospital - Atlanta
New York
- NYU Langone Health - Brooklyn
- NYU Langone Health - New York
- Columbia University Medical Center - New York
Florida
- Morton Plant Hospital - Clearwater
- Tallahassee Research Institute - Tallahassee
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
Colorado
- South Denver Cardiology Associates, P.C - Littleton
Connecticut
- Yale New Haven Hospital - New Haven
Illinois
- Northwestern University - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2023-05-03 |
| Est. Completion | 2028-04 |
What the registry record for NCT05755711 still lists
NCT05755711 is an observational study that tracks outcomes without assigning an intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Shockwave Medical Coronary IVL System is the first listed.
NCT05755711 names 20 study sites across 11 states, led by California, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT05755711 about?
NCT05755711 is a clinical study titled "Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease". Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
What is the current status of trial NCT05755711?
This trial is currently active not recruiting. The enrollment target is 399 participants. The study started on 2023-05-03. Estimated completion is 2028-04.
What conditions does trial NCT05755711 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT05755711?
The interventions under investigation include: Shockwave Medical Coronary IVL System (DEVICE).
Who is sponsoring clinical trial NCT05755711?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05755711 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05755711's enrollment target sits among peer trials
399 90th of 219 higher than 130 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI